CINECA IRIS Institutional Research Information System

ORTORE, GABRIELLA MARIA PIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.057
AS - Asia 3.517
EU - Europa 2.471
SA - Sud America 463
AF - Africa 113
OC - Oceania 6
Totale 12.627
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.879
CN - Cina 1.379
IT - Italia 959
SG - Singapore 927
HK - Hong Kong 399
BR - Brasile 384
DE - Germania 326
SE - Svezia 292
VN - Vietnam 224
BG - Bulgaria 172
FR - Francia 168
TR - Turchia 167
CA - Canada 128
GB - Regno Unito 126
FI - Finlandia 107
IN - India 94
KR - Corea 85
UA - Ucraina 81
RU - Federazione Russa 65
JP - Giappone 59
AT - Austria 33
BD - Bangladesh 31
CH - Svizzera 30
NL - Olanda 26
PK - Pakistan 26
AR - Argentina 24
MX - Messico 24
MA - Marocco 20
ZA - Sudafrica 20
ES - Italia 19
CI - Costa d'Avorio 18
ID - Indonesia 18
IQ - Iraq 17
BE - Belgio 15
PL - Polonia 14
EC - Ecuador 13
SN - Senegal 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
IR - Iran 10
NG - Nigeria 9
SA - Arabia Saudita 9
CO - Colombia 8
EG - Egitto 7
PE - Perù 7
TN - Tunisia 7
VE - Venezuela 7
TT - Trinidad e Tobago 6
UY - Uruguay 6
CL - Cile 5
IL - Israele 5
NP - Nepal 5
PY - Paraguay 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
IE - Irlanda 4
JM - Giamaica 4
JO - Giordania 4
KW - Kuwait 4
LB - Libano 4
PH - Filippine 4
TW - Taiwan 4
BJ - Benin 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
QA - Qatar 3
BB - Barbados 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
ZM - Zambia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CU - Cuba 1
DM - Dominica 1
GR - Grecia 1
HN - Honduras 1
JE - Jersey 1
KE - Kenya 1
KI - Kiribati 1
Totale 12.613
Salva come PNG Salva come JPEG
Città #
Ashburn 610
Woodbridge 585
Singapore 542
Ann Arbor 523
Chengdu 509
Houston 423
San Jose 395
Hong Kong 393
Fairfield 350
Santa Clara 327
Dallas 326
Chandler 318
Milan 206
Sofia 171
Beijing 167
Shanghai 157
Serra 135
Seattle 133
Wilmington 131
Izmir 126
New York 120
Pisa 115
Jacksonville 107
Hefei 105
Cambridge 101
Los Angeles 98
Ottawa 95
Boardman 88
Seoul 85
Princeton 72
Lauterbourg 70
Nanjing 69
Lawrence 66
Council Bluffs 64
Tokyo 54
Medford 52
Florence 48
Munich 45
Dearborn 44
Ho Chi Minh City 44
Redondo Beach 40
Des Moines 39
Hanoi 35
Boulder 34
Columbus 32
Istanbul 31
Dong Ket 30
Marseille 30
Nanchang 28
San Diego 27
Bern 26
London 26
Vienna 25
São Paulo 24
Rome 23
Buffalo 21
Helsinki 21
The Dalles 21
Lucca 20
Ogden 20
Turku 20
Jüchen 19
Abidjan 18
Chennai 18
Trieste 18
Frankfurt am Main 17
Kunming 17
Redwood City 17
Nürnberg 16
Chicago 15
Brussels 14
Guangzhou 14
Orem 14
Porcia 14
Rio de Janeiro 14
Dakar 13
Fuzhou 13
Pescara 13
Casablanca 12
Hangzhou 12
Jakarta 12
Tianjin 12
Da Nang 11
Dhaka 11
Genoa 11
Pune 11
Shenyang 11
Stockholm 11
Amsterdam 10
Baltimore 10
Falls Church 10
Hebei 10
Pessac 10
Tashkent 10
Toronto 10
Warsaw 10
Belo Horizonte 9
Bergamo 9
Brno 9
Brooklyn 9
Totale 9.136
Salva come PNG Salva come JPEG
Nome #
null 595
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 236
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration 235
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 230
A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by using a Pharmacophore-Based Approach 219
Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode 216
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 209
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 203
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 203
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 202
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 202
D3 dopamine receptor subtype: which binding modes for such different ligands?, 200
Identification of new FYN kinase inhibitors using a FLAP-based approach 197
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 196
Synthesis and dopaminergic properties of the two enantiomers of 3-(3,4-dimethylphenyl)-1-propylpiperidine, a potent and selective dopamine D4 receptor ligand 195
Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis 192
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 190
Computational studies of EGFR inhibitors: Docking, 3D-QSAR analysis and virtual screening evaluation 189
D3 dopamine receptor subtype: which binding modes for such different ligands? 187
Design of transthyretin amyloidosis inhibitors: A docking and virtual screening approach 180
Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis 179
Exploring the binding of quercetin-3-O-metabolites with transthyretin 177
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives 175
Different Binding Modes of Structurally Diverse Ligands for Human D3DAR 175
Computational Studies on Translocator Protein (TSPO) and its Ligands 174
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 168
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 168
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors 167
New N-n-propyl-substituted 3-Aryl and 3-Cyclohexyl piperidines as partial agonists at the D4 dopamine receptor 167
Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors 163
Aryl-substituted methyleneaminoxymethyl (MAOM) analogues of diarylcyclopentenyl cyclooxygenase-2 inhibitors: effects of some structural modifications on their biological properties 163
The cannabinoid CB2/CB1 selectivity. Homology modelling and automated docking analysis 161
Structure-based virtual screening: Identification of novel CB2 receptor ligands 161
Transthyretin amyloidosis: a computational approach toward the design of new inhibitors 159
Unraveling the Protective Role of Oleocanthal and Its Oxidation Product, Oleocanthalic Acid, against Neuroinflammation 156
Novel Estrogen Receptor Ligands Based on an Anthranylaldoxime Structure: Role of the Phenol-Type Pseudocycle in the Binding Process 155
Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors 154
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 153
Adenosine receptor modelling. A1/A2a selectivity 151
Synthesis and prostaglandin synthase inhibitory activity of new aromatic O-alkyloxime ethers substituted with methylsulfonamido or methylsulfonyl groups on their aliphatic portion 150
Confronto fra le affinità verso i recettori adenosinici umani e bovini di ligandi selettivi 1,8-naftiridinici. 148
Study on Affinity Profile toward Native and Bovine Adenosine Receptors of a Series of 1,8-Naphthyridine Derivatives 148
Identification of Transthyretin Fibril Formation Inhibitors Using Structure-Based Virtual Screening 146
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis 145
Synthesis and COX2 inhibitory properties of N-Phenyl-and N-benzyl-substituted amides of 2-(4-methylsulfonylphenyl)cyclopent-1-ene-1-carboxylic acid and of their pyrazole, thiophene, and isoxazole analogs 145
Aromatic aldoximes as Estrogen Receptor Beta–Selective Ligands 143
SERINE PALMITOYLTRANSFERASE INHIBITION: A VIRTUAL SCREENING HYPOTHESIS 142
A theoretical study to investigate D2DAR/D4DAR selectivity: Receptor modeling and molecular docking of dopaminergic ligands 142
Diphenyl-methane based thyromimetic inhibitors for transthyretin amyloidosis 139
Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study 135
A STRUCTURE-BASED VIRTUAL SCREENING TO IDENTIFY NEW SCAFFOLDS FOR TRANSTHYRETIN FIBRIL FORMATION INHIBITORS 132
MMPs selectivity: Docking and 3D-QSAR evaluation 129
From Anti-infective Agents to Cancer Therapy: a Drug Repositioning Study Revealed a New Use for Nitrofuran Derivatives 129
Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile 128
Molecular docking of new highly potent A1 antagonists: theoretical study of a1 selectivity and species specificity in ligand binding 127
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 126
Predictions of binding of estrogen receptor agonists by a combination of molecular dynamics and continuum solvent models 125
Synthesis and biological properties of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as selective CB2 cannabinoid receptor ligands 124
null 117
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities 117
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R) 116
New inhibitors of transthyretin amyloid fibril formation 114
Nuovi derivati 3-fenil- e 3-cicloesil-piperidinici ad attività agonista sui recettori D4: un nuovo approccio per lo studio del deficit di attenzione con iperattività? 111
Selettività verso i recettori adenosinici: uno studio di modellazione molecolare 110
Alternatives to phenol-based estrogen receptor ligands 110
Derivati 1,8 naftiridinici: selettività e docking nei recettori adenosinico 108
Transthyretin: A Small Protein in the Big World of Amyloidoses 104
null 103
Salicil- ed antranil-aldossime ad azione estrogenica: ruolo dell’anello pseudo-fenolico 100
Sintesi e proprietà inibitrici nei confronti delle cicloossigenasi di ammidi dell'acido 2-(4-metilsulfonilfenil)-1-ciclopentenico e di suoi analoghi eteroaromatici 98
From Paroxetine to new chromane oxime ether derivatives: a novel scaffold for SERT inhibitors. 98
Homology Modelling and Receptor-Based 3D-QSAR study of Carbonic Anhydrase IX 97
null 92
null 86
Studio teorico di ligandi selettivi per i recettori adenosinici 85
Computational Studies on Transthyretin 83
null 81
Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities 78
Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors 77
INTERACTION OF AMINOADAMANTANE DERIVATIVES WITH THE INFLUENZA A VIRUS M2 CHANNEL – COMPARATIVE DOCKING CALCULATIONS USING A PORE BLOCKING MODEL AND AN ALLOSTERIC MODEL 74
Synthesis and biological evaluation of N–O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection 71
null 69
Molecular Modeling of Adenosine ReceptorsG Protein Coupled Receptors - Modeling, Activation, Interactions and Virtual Screening 67
null 65
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines 60
A2B Receptor Ligands: Past, Present and Future Trends 57
Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-Docking using a pore blocking model 55
Design, synthesis and docking study of novel series of thyromimetics for the treatment of MASLD 9
Totale 12.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022770 22 76 20 24 141 105 28 37 26 28 57 206
2022/2023988 100 116 68 83 91 155 11 66 164 5 47 82
2023/2024973 131 104 98 72 133 145 93 14 12 23 41 107
2024/20252.583 22 91 50 139 255 245 246 146 224 295 285 585
2025/20263.025 197 384 409 283 274 241 441 157 171 287 122 59
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 12.817